Nyxoah SA (NASDAQ:NYXH) Receives Average Recommendation of “Moderate Buy” from Brokerages
by Renee Jackson · The Cerbat GemShares of Nyxoah SA (NASDAQ:NYXH – Get Free Report) have received an average rating of “Moderate Buy” from the five analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $11.25.
Several equities analysts recently issued reports on the company. Stifel Nicolaus dropped their price target on Nyxoah from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, March 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nyxoah in a research report on Monday, December 29th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $11.00 price objective on shares of Nyxoah in a research note on Monday, March 23rd.
Institutional Investors Weigh In On Nyxoah
A number of hedge funds have recently added to or reduced their stakes in NYXH. Bank of America Corp DE boosted its stake in shares of Nyxoah by 152.7% in the third quarter. Bank of America Corp DE now owns 19,878 shares of the company’s stock valued at $91,000 after buying an additional 12,012 shares in the last quarter. Franklin Resources Inc. raised its position in Nyxoah by 0.9% in the second quarter. Franklin Resources Inc. now owns 294,990 shares of the company’s stock worth $2,207,000 after acquiring an additional 2,655 shares in the last quarter. Shay Capital LLC purchased a new position in Nyxoah in the second quarter worth $374,000. Heights Capital Management Inc. acquired a new stake in Nyxoah in the fourth quarter valued at $3,575,000. Finally, Deutsche Bank AG grew its stake in shares of Nyxoah by 40.0% during the 4th quarter. Deutsche Bank AG now owns 35,000 shares of the company’s stock worth $161,000 after purchasing an additional 10,000 shares during the period.
Nyxoah Price Performance
Shares of NASDAQ NYXH opened at $3.56 on Monday. The company has a quick ratio of 1.16, a current ratio of 1.25 and a debt-to-equity ratio of 0.37. The stock has a market cap of $137.99 million, a PE ratio of -1.33 and a beta of 1.66. The business has a 50-day moving average price of $3.97 and a 200 day moving average price of $4.67. Nyxoah has a 52-week low of $2.76 and a 52-week high of $8.64.
Nyxoah (NASDAQ:NYXH – Get Free Report) last released its quarterly earnings results on Saturday, February 14th. The company reported ($0.69) EPS for the quarter. Nyxoah had a negative net margin of 884.69% and a negative return on equity of 139.18%. The business had revenue of $6.62 million during the quarter. Equities research analysts forecast that Nyxoah will post -1.91 earnings per share for the current year.
Nyxoah Company Profile
Nyxoah SA, headquartered in Mont-Saint-Guibert, Belgium, is a medical technology company focused on neuromodulation therapies for sleep‐disordered breathing. Established in 2018, the company’s primary offering is the Genio® system, a minimally invasive bilateral hypoglossal nerve stimulator designed to treat moderate to severe obstructive sleep apnea (OSA). By electrically stimulating the genioglossus muscle, the device helps maintain airway patency during sleep, reducing apnea events and improving overall sleep quality.
The Genio system comprises a small, implantable stimulator positioned submentally and an external activation unit worn by the patient.